Don't miss out on the latest business and technology news for chemical engineers, featuring select items in relation to Food, Pharmaceuticals & Bioengineering!
Prexton purchased by Lundbeck for $1.1B
Prexton Therapeutics was purchased by H. Lundbeck in a deal that will give Prexton $122.9 million upfront and up to $989.1 million tied to achieving milestones. Under the deal, Lundbeck will add Prexton's midstage Parkinson's disease candidate to its pipeline of drugs for the treatment of neurological and psychiatric disorders.
US still an obstacle in Bayer-Monsanto talks
Antitrust regulators in the US may not be satisfied with Bayer's proposed asset sales as part of its deal with Monsanto and may require additional divestments, sources say. Separately, Bayer said negotiations with Russian regulators are advancing.
Transistors could be made with graphene flakes
A study by Italy's SISSA says nanoelectronics could be fabricated with graphene nanoflakes. The magnetic properties of such nanostructures could also benefit the development of spintronics technology.
Biotech company studies dehydration of red blood cells using trehalose
DesiCorp is studying the role of the molecule trehalose in allowing animals such as sea monkeys to survive dehydration and rehydration, and whether it could be used to extend the shelf life of red blood cells. The biotech has used sound waves to place the molecule in red blood cells, and its most successful tests have resulted in rehydration of about 50% of dehydrated red blood cells.
- Log in to post comments